Neill A Giese

Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family.

Keith Abe, Jin-Chen Yu, N. Giese, 2002, Journal of medicinal chemistry.

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

Donna Neuberg, Keith Abe, Ifor Williams, 2002, Cancer cell.